» Articles » PMID: 34696806

Conceptual Causal Framework to Assess the Effect of SARS-CoV-2 Variants on COVID-19 Disease Severity Among Hospitalized Patients

Overview
Publisher Biomed Central
Date 2021 Oct 26
PMID 34696806
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: SARS-CoV-2 strains evolve continuously and accumulate mutations in their genomes over the course of the pandemic. The severity of a SARS-CoV-2 infection could partly depend on these viral genetic characteristics. Here, we present a general conceptual framework that allows to study the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients.

Methods: A causal model is defined and visualized using a Directed Acyclic Graph (DAG), in which assumptions on the relationship between (confounding) variables are made explicit. Various DAGs are presented to explore specific study design options and the risk for selection bias. Next, the data infrastructure specific to the COVID-19 surveillance in Belgium is described, along with its strengths and weaknesses for the study of clinical impact of variants.

Discussion: A well-established framework that provides a complete view on COVID-19 disease severity among hospitalized patients by combining information from different sources on host factors, viral factors, and healthcare-related factors, will enable to assess the clinical impact of emerging SARS-CoV-2 variants and answer questions that will be raised in the future. The framework shows the complexity related to causal research, the corresponding data requirements, and it underlines important limitations, such as unmeasured confounders or selection bias, inherent to repurposing existing routine COVID-19 data registries.

Trial Registration: Each individual research project within the current conceptual framework will be prospectively registered in Open Science Framework (OSF identifier: https://doi.org/10.17605/OSF.IO/UEF29 ). OSF project created on 18 May 2021.

Citing Articles

Area and individual level analyses of demographic and socio-economic disparities in COVID-19 vaccination uptake in Belgium.

Hubin P, Van den Borre L, Braeye T, Cavillot L, Billuart M, Stouten V Vaccine X. 2024; 18:100496.

PMID: 38779406 PMC: 11108972. DOI: 10.1016/j.jvacx.2024.100496.


The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022).

Willem L, Abrams S, Franco N, Coletti P, Libin P, Wambua J BMC Public Health. 2024; 24(1):1171.

PMID: 38671366 PMC: 11047051. DOI: 10.1186/s12889-024-18576-w.


Sociodemographic and socioeconomic disparities in COVID-19 vaccine uptake in Belgium: a nationwide record linkage study.

Cavillot L, van Loenhout J, Devleesschauwer B, Wyndham-Thomas C, Van Oyen H, Ghattas J J Epidemiol Community Health. 2023; .

PMID: 38148149 PMC: 11045363. DOI: 10.1136/jech-2023-220751.


Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium.

Meurisse M, Catteau L, van Loenhout J, Braeye T, de Mot L, Serrien B Vaccines (Basel). 2023; 11(2).

PMID: 36851257 PMC: 9961733. DOI: 10.3390/vaccines11020378.


Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study.

Robalo Q, de Mot L, Vandromme M, Van Goethem N, Gabrio A, Chung P Vaccines (Basel). 2023; 11(1).

PMID: 36679859 PMC: 9866568. DOI: 10.3390/vaccines11010014.


References
1.
Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K . SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J Hum Genet. 2020; 65(12):1075-1082. PMC: 7375454. DOI: 10.1038/s10038-020-0808-9. View

2.
Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P . Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020; 383(16):1522-1534. PMC: 7315890. DOI: 10.1056/NEJMoa2020283. View

3.
Zimmermann P, Curtis N . Factors That Influence the Immune Response to Vaccination. Clin Microbiol Rev. 2019; 32(2). PMC: 6431125. DOI: 10.1128/CMR.00084-18. View

4.
Killerby M, Link-Gelles R, Haight S, Schrodt C, England L, Gomes D . Characteristics Associated with Hospitalization Among Patients with COVID-19 - Metropolitan Atlanta, Georgia, March-April 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(25):790-794. PMC: 7316317. DOI: 10.15585/mmwr.mm6925e1. View

5.
Meurisse M, Lajot A, Dupont Y, Lesenfants M, Klamer S, Rebolledo J . One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020-21). Arch Public Health. 2021; 79(1):188. PMC: 8548266. DOI: 10.1186/s13690-021-00704-2. View